NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K-RAS mutation occurrence in Taiwanese colorectal cancer

Chi Chou Huang, Wen Pin Chien, Ruey Hong Wong, Ya Wen Cheng, Meng Cheng Chen, Huei Lee

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

A recent study conducted by our group showed that the NAT2 fast acetylator genotype is associated with an increasing risk for the development of colorectal cancer (CRC), especially for females. We therefore examined whether a higher risk of CRC in females with the NAT2 fast acetylator genotype was associated with the occurrence of KRAS mutation, and to further verify whether MGMT promoter methylation was linked to the occurrence of K-RAS mutation in patients with the NAT2 fast acetylator genotype. Herein, 151 CRC cases were examined for NAT2 genetic polymorphisms and MGMT promoter methylation by PCRRFLP and methylation-specific PCR (MSP). The results of this study show that the NAT2 fast acetylator genotype is associated with the occurrence of K-RAS mutation in female cases (OR = 4.820, 95% CI = 1.113-20.873), but not associated with MGMT promoter methylation. Surprisingly, MGMT promoter methylation significantly deepens the impact of NAT2 fast acetylation on K-RAS mutation in the female cases (OR = 5.129, 95% CI = 1.092-24.105). In conclusion, Taiwanese women with the NAT2 fast acetylator genotype may exhibit a higher risk of CRC with increased occurrence of K-RAS mutation. Detection of NAT2 genotypes and MGMT promoter methylation may be useful in the risk assessment for CRC in Taiwanese women.

Original languageEnglish
Pages (from-to)127-133
Number of pages7
JournalEnvironmental and Molecular Mutagenesis
Volume50
Issue number2
DOIs
Publication statusPublished - Mar 2009
Externally publishedYes

Fingerprint

Methylation
Colorectal Neoplasms
Genotype
Mutation
Genetic Polymorphisms
Acetylation
Polymerase Chain Reaction

Keywords

  • Colorectal cancer
  • K-RAS mutation
  • MGMT hypermethylation
  • NAT2 genotypes
  • Taiwan

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Epidemiology
  • Genetics(clinical)

Cite this

NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K-RAS mutation occurrence in Taiwanese colorectal cancer. / Huang, Chi Chou; Chien, Wen Pin; Wong, Ruey Hong; Cheng, Ya Wen; Chen, Meng Cheng; Lee, Huei.

In: Environmental and Molecular Mutagenesis, Vol. 50, No. 2, 03.2009, p. 127-133.

Research output: Contribution to journalArticle

Huang, Chi Chou ; Chien, Wen Pin ; Wong, Ruey Hong ; Cheng, Ya Wen ; Chen, Meng Cheng ; Lee, Huei. / NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K-RAS mutation occurrence in Taiwanese colorectal cancer. In: Environmental and Molecular Mutagenesis. 2009 ; Vol. 50, No. 2. pp. 127-133.
@article{1bd5f9dc6748433f94b222858eed7fa0,
title = "NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K-RAS mutation occurrence in Taiwanese colorectal cancer",
abstract = "A recent study conducted by our group showed that the NAT2 fast acetylator genotype is associated with an increasing risk for the development of colorectal cancer (CRC), especially for females. We therefore examined whether a higher risk of CRC in females with the NAT2 fast acetylator genotype was associated with the occurrence of KRAS mutation, and to further verify whether MGMT promoter methylation was linked to the occurrence of K-RAS mutation in patients with the NAT2 fast acetylator genotype. Herein, 151 CRC cases were examined for NAT2 genetic polymorphisms and MGMT promoter methylation by PCRRFLP and methylation-specific PCR (MSP). The results of this study show that the NAT2 fast acetylator genotype is associated with the occurrence of K-RAS mutation in female cases (OR = 4.820, 95{\%} CI = 1.113-20.873), but not associated with MGMT promoter methylation. Surprisingly, MGMT promoter methylation significantly deepens the impact of NAT2 fast acetylation on K-RAS mutation in the female cases (OR = 5.129, 95{\%} CI = 1.092-24.105). In conclusion, Taiwanese women with the NAT2 fast acetylator genotype may exhibit a higher risk of CRC with increased occurrence of K-RAS mutation. Detection of NAT2 genotypes and MGMT promoter methylation may be useful in the risk assessment for CRC in Taiwanese women.",
keywords = "Colorectal cancer, K-RAS mutation, MGMT hypermethylation, NAT2 genotypes, Taiwan",
author = "Huang, {Chi Chou} and Chien, {Wen Pin} and Wong, {Ruey Hong} and Cheng, {Ya Wen} and Chen, {Meng Cheng} and Huei Lee",
year = "2009",
month = "3",
doi = "10.1002/em.20444",
language = "English",
volume = "50",
pages = "127--133",
journal = "Environmental and Molecular Mutagenesis",
issn = "0893-6692",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K-RAS mutation occurrence in Taiwanese colorectal cancer

AU - Huang, Chi Chou

AU - Chien, Wen Pin

AU - Wong, Ruey Hong

AU - Cheng, Ya Wen

AU - Chen, Meng Cheng

AU - Lee, Huei

PY - 2009/3

Y1 - 2009/3

N2 - A recent study conducted by our group showed that the NAT2 fast acetylator genotype is associated with an increasing risk for the development of colorectal cancer (CRC), especially for females. We therefore examined whether a higher risk of CRC in females with the NAT2 fast acetylator genotype was associated with the occurrence of KRAS mutation, and to further verify whether MGMT promoter methylation was linked to the occurrence of K-RAS mutation in patients with the NAT2 fast acetylator genotype. Herein, 151 CRC cases were examined for NAT2 genetic polymorphisms and MGMT promoter methylation by PCRRFLP and methylation-specific PCR (MSP). The results of this study show that the NAT2 fast acetylator genotype is associated with the occurrence of K-RAS mutation in female cases (OR = 4.820, 95% CI = 1.113-20.873), but not associated with MGMT promoter methylation. Surprisingly, MGMT promoter methylation significantly deepens the impact of NAT2 fast acetylation on K-RAS mutation in the female cases (OR = 5.129, 95% CI = 1.092-24.105). In conclusion, Taiwanese women with the NAT2 fast acetylator genotype may exhibit a higher risk of CRC with increased occurrence of K-RAS mutation. Detection of NAT2 genotypes and MGMT promoter methylation may be useful in the risk assessment for CRC in Taiwanese women.

AB - A recent study conducted by our group showed that the NAT2 fast acetylator genotype is associated with an increasing risk for the development of colorectal cancer (CRC), especially for females. We therefore examined whether a higher risk of CRC in females with the NAT2 fast acetylator genotype was associated with the occurrence of KRAS mutation, and to further verify whether MGMT promoter methylation was linked to the occurrence of K-RAS mutation in patients with the NAT2 fast acetylator genotype. Herein, 151 CRC cases were examined for NAT2 genetic polymorphisms and MGMT promoter methylation by PCRRFLP and methylation-specific PCR (MSP). The results of this study show that the NAT2 fast acetylator genotype is associated with the occurrence of K-RAS mutation in female cases (OR = 4.820, 95% CI = 1.113-20.873), but not associated with MGMT promoter methylation. Surprisingly, MGMT promoter methylation significantly deepens the impact of NAT2 fast acetylation on K-RAS mutation in the female cases (OR = 5.129, 95% CI = 1.092-24.105). In conclusion, Taiwanese women with the NAT2 fast acetylator genotype may exhibit a higher risk of CRC with increased occurrence of K-RAS mutation. Detection of NAT2 genotypes and MGMT promoter methylation may be useful in the risk assessment for CRC in Taiwanese women.

KW - Colorectal cancer

KW - K-RAS mutation

KW - MGMT hypermethylation

KW - NAT2 genotypes

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=60849106685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60849106685&partnerID=8YFLogxK

U2 - 10.1002/em.20444

DO - 10.1002/em.20444

M3 - Article

C2 - 19107910

AN - SCOPUS:60849106685

VL - 50

SP - 127

EP - 133

JO - Environmental and Molecular Mutagenesis

JF - Environmental and Molecular Mutagenesis

SN - 0893-6692

IS - 2

ER -